Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Clinical trial NCT00468286 · COMPLETED
Trial details
- NCT number
- NCT00468286
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-08-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.